NVIDIA CORPNVIDIA CORP

Institutional investor · Portfolio as of Q1 2025

Top Holdings6 positions

Checking export access…
Activity:

COREWEAVE INC

24.2M$896.7M78.2%$37.080.00%
1 qtr
New
100
ARMARM
ADR

ARM HOLDINGS PLC

1.1M$117.6M10.3%$75.14+43.47%
6 qtrssince 2023-Q4
Unchanged
0

APPLIED DIGITAL CORP

7.7M$43.4M3.8%$8.25-31.88%
3 qtrssince 2024-Q3
Unchanged
0

RECURSION PHARMACEUTICALS IN

7.7M$40.8M3.6%$9.86-41.08%
6 qtrssince 2023-Q4
Unchanged
0

NEBIUS GROUP N.V.

1.2M$25.1M2.2%$26.92-17.12%
2 qtrssince 2024-Q4
Unchanged
0
WRDWRD
ADR

WERIDE INC

1.7M$23.6M2.1%$13.85+4.84%
2 qtrssince 2024-Q4
Unchanged
0
$1.1B
AUM
6
Positions
Q1 2025
Filing
HI score · 2.0/5
Quarterly 13F Value Change
+10%Q3'24$432.9M-30%Q4'24$304.5M+277%Q1'25$1.1B
Activity profile
$ moved · Q1'25
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.3 quarters
<1Q17%1-4Q50%1-2Y33%2Y+0%

NVIDIA CORP manages $1.1B across 6 positions as of Q1 2025. Top holdings: CRWV (78.2%), ARM (10.3%), APLD (3.8%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2/5.0.

Q1 2025 Summary

Added 1 new position. Top move: CRWV (NEW, conviction 100). Portfolio: $1.1B across 6 positions.

Top holdings by portfolio weight

Total AUM$1B
CRWV78.17%
ARM10.25%
APLD3.78%
RXRX3.55%
NBIS2.19%
WRD2.06%

Portfolio allocation by GICS sector

Sectors3
Technology94.26%
Healthcare3.55%
Communication Services2.19%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L71
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used